US6018032A
(en)
*
|
1995-09-11 |
2000-01-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Antibody against human interleukin-5-receptor α chain
|
US6986890B1
(en)
|
1996-11-21 |
2006-01-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti-human VEGF receptor Flt-1 monoclonal antibody
|
WO1999060025A1
(fr)
*
|
1998-05-20 |
1999-11-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticorps recombines de gene
|
JP3679406B2
(ja)
*
|
1998-05-20 |
2005-08-03 |
協和醗酵工業株式会社 |
遺伝子組換え抗体
|
FR2783326B1
(fr)
*
|
1998-09-10 |
2000-12-01 |
Immunotech Sa |
Procede de detection ou de quantification des basophiles et des eosinophiles
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
EP2264166B1
(en)
|
1999-04-09 |
2016-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
IT1306704B1
(it)
|
1999-05-26 |
2001-10-02 |
Sirs Societa Italiana Per La R |
Anticorpi monoclonali e suoi derivati sintetici o biotecnologici ingrado di agire come molecole antagoniste per il ngf.
|
ES2301491T3
(es)
*
|
1999-09-30 |
2008-07-01 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticuerpo humano de trasplante con region de determinacion de la complementariedad contra gangliosido gd3 y derivados del anticuerpo contra gangliosido gd3.
|
US7504256B1
(en)
*
|
1999-10-19 |
2009-03-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Process for producing polypeptide
|
US7404953B2
(en)
*
|
2000-02-15 |
2008-07-29 |
Kyowa Hakko Kogyo Co., Ltd. |
Methods using eosinophil-specific apoptosis inducer
|
WO2001064711A1
(fr)
*
|
2000-03-02 |
2001-09-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Procede de separation et de purification de proteine
|
US20030023043A1
(en)
*
|
2000-03-02 |
2003-01-30 |
Kazuhisa Uchida |
Method of separating and purifying protein
|
EP1270595B1
(en)
|
2000-03-03 |
2008-07-23 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti ccr4 antibody and its fragment
|
FR2807767B1
(fr)
*
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
US7384632B2
(en)
*
|
2000-06-22 |
2008-06-10 |
Genentech, Inc. |
Agonist anti-trk-C monoclonal antibodies
|
DK2314686T4
(da)
|
2000-10-06 |
2023-08-21 |
Kyowa Kirin Co Ltd |
Celler, der danner antistofsammensætninger
|
US6946292B2
(en)
*
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
US7064191B2
(en)
*
|
2000-10-06 |
2006-06-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Process for purifying antibody
|
CA2424977C
(en)
*
|
2000-10-06 |
2008-03-18 |
Kyowa Hakko Kogyo Co., Ltd. |
Process for purifying antibody
|
WO2003018635A1
(en)
|
2001-08-31 |
2003-03-06 |
Kyowa Hakko Kogyo Co., Ltd. |
Human cdr-grafted antibodies and antibody fragments thereof
|
US7691568B2
(en)
|
2002-04-09 |
2010-04-06 |
Kyowa Hakko Kirin Co., Ltd |
Antibody composition-containing medicament
|
JP2003310275A
(ja)
*
|
2002-04-30 |
2003-11-05 |
Kyowa Hakko Kogyo Co Ltd |
ヒトインスリン様成長因子に対する遺伝子組換え抗体
|
GB0210783D0
(en)
*
|
2002-05-10 |
2002-06-19 |
Polonelli Luciano |
Anti-microbial polypeptides
|
EP1388544A1
(en)
*
|
2002-07-31 |
2004-02-11 |
D. Collen Research Foundation vzw |
Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof
|
EP1587834B1
(en)
|
2002-12-23 |
2011-07-06 |
Schering Corporation |
Uses of il-23 mammalian cytokine; related reagents
|
JP4794301B2
(ja)
|
2003-06-11 |
2011-10-19 |
中外製薬株式会社 |
抗体の製造方法
|
US7498415B2
(en)
|
2003-09-24 |
2009-03-03 |
Kyowa Hakko Kogyo Co., Ltd. |
Recombinant antibody against human insulin-like growth factor
|
US20050226867A1
(en)
*
|
2003-10-08 |
2005-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
IL-5R-specific antibody composition
|
CA2542042A1
(en)
*
|
2003-10-08 |
2005-04-21 |
Kyowa Hakko Kogyo Co., Ltd. |
Antibody composition specifically binding to il-5 receptor
|
US7326567B2
(en)
*
|
2003-11-12 |
2008-02-05 |
Schering Corporation |
Plasmid system for multigene expression
|
TW200530269A
(en)
|
2003-12-12 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Anti-Mpl antibodies
|
CA2558805C
(en)
*
|
2004-03-23 |
2011-09-27 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
US8192736B2
(en)
|
2004-10-28 |
2012-06-05 |
Kyowa Hakko Kirin Co., Ltd |
Remedy for endometriosis
|
JP5057967B2
(ja)
|
2005-03-31 |
2012-10-24 |
中外製薬株式会社 |
sc(Fv)2構造異性体
|
EP3050963B1
(en)
|
2005-03-31 |
2019-09-18 |
Chugai Seiyaku Kabushiki Kaisha |
Process for production of polypeptide by regulation of assembly
|
KR101367544B1
(ko)
|
2005-06-10 |
2014-02-26 |
추가이 세이야쿠 가부시키가이샤 |
메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
|
US9241994B2
(en)
|
2005-06-10 |
2016-01-26 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical compositions containing sc(Fv)2
|
WO2007066698A1
(ja)
|
2005-12-06 |
2007-06-14 |
Kyowa Hakko Kogyo Co., Ltd. |
抗perp遺伝子組換え抗体
|
EP4218801A3
(en)
|
2006-03-31 |
2023-08-23 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody modification method for purifying bispecific antibody
|
WO2007114319A1
(ja)
|
2006-03-31 |
2007-10-11 |
Chugai Seiyaku Kabushiki Kaisha |
抗体の血中動態を制御する方法
|
US20080118978A1
(en)
|
2006-04-28 |
2008-05-22 |
Takashi Sato |
Anti-tumor agent
|
CN101511870B
(zh)
|
2006-06-06 |
2014-04-09 |
协和发酵麒麟株式会社 |
能够与肝素结合性表皮生长因子样生长因子结合的单克隆抗体
|
BRPI0712426B1
(pt)
|
2006-06-08 |
2021-10-26 |
Chugai Seiyaku Kabushiki Kaisha |
Usos de um anticorpo anti-nr10/il-31ra com atividade neutralizante de nr10/il-31ra, de um fragmento e/ou um fragmento quimicamente modificado do anticorpo e de um agente
|
ES2538990T3
(es)
|
2007-01-24 |
2015-06-25 |
Kyowa Hakko Kirin Co., Ltd. |
Composición de anticuerpo genéticamente recombinante que tiene una actividad efectora mejorada
|
US20110236374A1
(en)
|
2007-01-24 |
2011-09-29 |
Kyowa Hakko Kirin Co., Ltd. |
Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
|
KR100855299B1
(ko)
|
2007-02-16 |
2008-08-29 |
건국대학교 산학협력단 |
인간 il-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 il-32측정법
|
JPWO2008114733A1
(ja)
|
2007-03-16 |
2010-07-01 |
協和発酵キリン株式会社 |
抗Claudin−4抗体
|
PT2068927E
(pt)
*
|
2007-05-14 |
2016-02-10 |
Medimmune Llc |
Métodos para reduzir os níveis de eosinófilos
|
TWI464262B
(zh)
|
2007-09-26 |
2014-12-11 |
中外製藥股份有限公司 |
抗體固定區的變異
|
JP5334319B2
(ja)
*
|
2007-09-26 |
2013-11-06 |
中外製薬株式会社 |
Cdrのアミノ酸置換により抗体の等電点を改変する方法
|
JP5532401B2
(ja)
|
2007-12-05 |
2014-06-25 |
協和発酵キリン株式会社 |
ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体
|
EP2241332A4
(en)
|
2007-12-05 |
2011-01-26 |
Chugai Pharmaceutical Co Ltd |
THERAPEUTIC AGENT AGAINST PRITURE
|
EP2236604B1
(en)
*
|
2007-12-05 |
2016-07-06 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-nr10 antibody and use thereof
|
PT2238170T
(pt)
|
2008-01-31 |
2017-02-21 |
Inserm - Inst Nat De La Santé Et De La Rech Médicale |
Anticorpos contra cd39 humano e seu uso para inibição da actividade de células t reguladoras
|
PL2708558T3
(pl)
|
2008-04-11 |
2018-09-28 |
Chugai Seiyaku Kabushiki Kaisha |
Cząsteczka wiążąca antygen zdolna do wiązania dwóch lub więcej cząsteczek antygenu w sposób powtarzalny
|
US9023999B2
(en)
|
2008-06-30 |
2015-05-05 |
Kyowa Hakko Kirin Co., Ltd |
Anti-CD27 antibody
|
WO2010008075A1
(ja)
|
2008-07-17 |
2010-01-21 |
協和発酵キリン株式会社 |
抗システムascアミノ酸トランスポーター2(asct2)抗体
|
WO2010018847A1
(ja)
|
2008-08-13 |
2010-02-18 |
協和発酵キリン株式会社 |
遺伝子組換えプロテインs組成物
|
US8481033B2
(en)
|
2008-10-07 |
2013-07-09 |
INSERM (Institute National de la Santé et de la Recherche Médicale) |
Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)
|
KR20160062207A
(ko)
*
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항nr10 항체 및 그의 이용
|
JP5139517B2
(ja)
*
|
2008-12-05 |
2013-02-06 |
中外製薬株式会社 |
抗nr10抗体、およびその利用
|
WO2010074266A1
(ja)
|
2008-12-26 |
2010-07-01 |
協和発酵キリン株式会社 |
抗cd4抗体
|
JP2010210772A
(ja)
*
|
2009-03-13 |
2010-09-24 |
Dainippon Screen Mfg Co Ltd |
液晶表示装置の製造方法
|
WO2010106051A1
(en)
|
2009-03-17 |
2010-09-23 |
Universite De La Mediterranee |
Btla antibodies and uses thereof
|
TWI682995B
(zh)
|
2009-03-19 |
2020-01-21 |
日商中外製藥股份有限公司 |
抗體恆定區域改變體
|
JP5717624B2
(ja)
|
2009-03-19 |
2015-05-13 |
中外製薬株式会社 |
抗体定常領域改変体
|
CA2759146C
(en)
|
2009-04-20 |
2017-06-13 |
Kyowa Hakko Kirin Co., Ltd. |
Agonist anti-cd40 antibody
|
EP2463368B1
(en)
|
2009-08-07 |
2018-01-10 |
Kyowa Hakko Kirin Co., Ltd. |
Humanized anti-amyloid-b oligomer antibody
|
WO2011016568A1
(ja)
|
2009-08-07 |
2011-02-10 |
協和発酵キリン株式会社 |
抗アミロイドβオリゴマーヒト化抗体
|
JP5709061B2
(ja)
|
2009-09-10 |
2015-04-30 |
協和発酵キリン株式会社 |
ヒトccケモカイン受容体4(ccr4)に特異的に結合する抗体組成物を含む医薬
|
JP5837821B2
(ja)
|
2009-09-24 |
2015-12-24 |
中外製薬株式会社 |
抗体定常領域改変体
|
EP2543727B1
(en)
|
2010-03-02 |
2016-08-31 |
Kyowa Hakko Kirin Co., Ltd. |
Modified antibody composition
|
EP2543730B1
(en)
|
2010-03-04 |
2018-10-31 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody constant region variant
|
JP5767207B2
(ja)
|
2010-03-26 |
2015-08-19 |
協和発酵キリン株式会社 |
新規修飾部位導入抗体および抗体フラグメント
|
TWI629483B
(zh)
|
2010-06-11 |
2018-07-11 |
協和醱酵麒麟有限公司 |
anti-TIM-3 antibody
|
US9040671B2
(en)
|
2010-07-23 |
2015-05-26 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods for cancer management targeting Co-029
|
ES2660151T3
(es)
|
2010-11-17 |
2018-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
Molécula de unión a antígeno multiespecífica que tiene función alternativa a la función del factor VIII de coagulación sanguínea
|
WO2012073992A1
(ja)
|
2010-11-30 |
2012-06-07 |
中外製薬株式会社 |
複数分子の抗原に繰り返し結合する抗原結合分子
|
WO2012080769A1
(en)
|
2010-12-15 |
2012-06-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-cd277 antibodies and uses thereof
|
ES2684602T3
(es)
|
2010-12-22 |
2018-10-03 |
Orega Biotech |
Anticuerpos contra CD39 humano y uso de los mismos
|
WO2012101125A1
(en)
|
2011-01-24 |
2012-08-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific antibodies against human cxcl4 and uses thereof
|
MX2013009859A
(es)
|
2011-03-01 |
2014-02-28 |
Novo Nordisk As |
Ligandos dr3 antagonicos.
|
WO2012130831A1
(en)
|
2011-03-29 |
2012-10-04 |
Roche Glycart Ag |
Antibody fc variants
|
JP6220774B2
(ja)
|
2011-03-31 |
2017-10-25 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Icosに対する抗体及びその使用
|
WO2012153707A1
(ja)
|
2011-05-09 |
2012-11-15 |
株式会社ペルセウスプロテオミクス |
トランスフェリン受容体を特異的に認識できる抗体
|
WO2012156532A1
(en)
|
2011-05-19 |
2012-11-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-human-her3 antibodies and uses thereof
|
CN103781800A
(zh)
|
2011-06-20 |
2014-05-07 |
协和发酵麒麟株式会社 |
抗erbB3抗体
|
KR20140104944A
(ko)
|
2011-06-22 |
2014-08-29 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
항-axl 항체 및 그의 용도
|
ES2677367T3
(es)
|
2011-06-22 |
2018-08-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anticuerpos anti-Axl y usos de los mismos
|
EP2543679A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543678A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543677A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
KR102168733B1
(ko)
|
2011-10-31 |
2020-10-23 |
추가이 세이야쿠 가부시키가이샤 |
중쇄와 경쇄의 회합이 제어된 항원 결합 분자
|
CA2853858A1
(en)
*
|
2011-11-01 |
2013-05-10 |
Medimmune, Llc |
Methods for reducing the frequency and severity of acute exacerbations of asthma
|
US9676847B2
(en)
|
2012-06-25 |
2017-06-13 |
Orega Biotech |
IL-17 antagonist antibodies
|
EP2868667B1
(en)
|
2012-07-02 |
2019-01-30 |
Kyowa Hakko Kirin Co., Ltd. |
Therapeutic agent for anemia including renal anemia and cancer-induced anemia which contains anti-bmp9 antibody as active ingredient
|
LT3495387T
(lt)
|
2012-07-13 |
2021-11-25 |
Roche Glycart Ag |
Bispecifiniai anti-vegf / anti-ang-2 antikūnai ir jų panaudojimas akių kraujagyslių ligoms gydyti
|
WO2014033327A1
(en)
|
2012-09-03 |
2014-03-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies directed against icos for treating graft-versus-host disease
|
JP6273205B2
(ja)
|
2012-10-05 |
2018-01-31 |
協和発酵キリン株式会社 |
ヘテロダイマータンパク質組成物
|
US9593165B2
(en)
|
2012-11-08 |
2017-03-14 |
University Of Miyazaki |
Antibody capable of specifically recognizing transferrin receptor
|
EP2733153A1
(en)
|
2012-11-15 |
2014-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the preparation of immunoconjugates and uses thereof
|
KR102408660B1
(ko)
|
2012-11-20 |
2022-06-15 |
사노피 |
항-ceacam5 항체 및 이의 용도
|
CN104884617B
(zh)
|
2012-12-07 |
2019-02-19 |
协和发酵麒麟株式会社 |
抗folr1抗体
|
WO2014102299A2
(en)
|
2012-12-27 |
2014-07-03 |
Sanofi |
Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof
|
WO2014183885A1
(en)
|
2013-05-17 |
2014-11-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antagonist of the btla/hvem interaction for use in therapy
|
ES2866426T3
(es)
|
2013-08-12 |
2021-10-19 |
Astrazeneca Ab |
Métodos para incrementar el volumen espiratorio forzado en pacientes asmáticos que usan benralizumab
|
EP3033103B1
(en)
|
2013-08-12 |
2019-06-05 |
AstraZeneca AB |
Methods for improving asthma symptoms using benralizumab
|
SI3033101T1
(sl)
|
2013-08-12 |
2019-04-30 |
Astrazeneca Ab |
Postopki zmanjševanja stopenj poslabšanja astme z uporabo benralizumaba
|
US10030071B2
(en)
|
2013-09-05 |
2018-07-24 |
University Of Miyazaki |
Antibody which specifically reacts with human integrin A6B4
|
US11124576B2
(en)
|
2013-09-27 |
2021-09-21 |
Chungai Seiyaku Kabushiki Kaisha |
Method for producing polypeptide heteromultimer
|
MX2016004329A
(es)
|
2013-10-15 |
2016-11-10 |
Astrazeneca Ab |
Metodos para tratar la enfermedad pulmonar obstructiva cronica usando benralizumab.
|
US20150118249A1
(en)
*
|
2013-10-24 |
2015-04-30 |
Medimmune, Llc |
Stable, Aqueous Antibody Formulations
|
US10196455B2
(en)
|
2013-11-07 |
2019-02-05 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Neuregulin allosteric anti-HER3 antibody
|
US10544231B2
(en)
|
2014-04-16 |
2020-01-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the prevention or the treatment of bleeding episodes
|
WO2016016442A1
(en)
|
2014-08-01 |
2016-02-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
An anti-cd45rc antibody for use as drug
|
MA40764A
(fr)
|
2014-09-26 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Agent thérapeutique induisant une cytotoxicité
|
WO2016059220A1
(en)
|
2014-10-16 |
2016-04-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Tcr-activating agents for use in the treatment of t-all
|
TW202130662A
(zh)
|
2015-01-23 |
2021-08-16 |
法商賽諾菲公司 |
特異性結合cd3及/或cd123之抗—cd3抗體,抗—cd123抗體及雙特異性抗體
|
MA41414A
(fr)
*
|
2015-01-28 |
2017-12-05 |
Centre Nat Rech Scient |
Protéines de liaison agonistes d' icos
|
AU2016232050B2
(en)
|
2015-03-18 |
2022-04-07 |
Janssen Vaccines & Prevention B.V. |
Assays for recombinant expression systems
|
US11142587B2
(en)
|
2015-04-01 |
2021-10-12 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing polypeptide hetero-oligomer
|
US20180071413A1
(en)
|
2015-04-07 |
2018-03-15 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Non-invasive imaging of tumor pd-l1 expression
|
WO2016167263A1
(ja)
|
2015-04-14 |
2016-10-20 |
中外製薬株式会社 |
Il-31アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び/又は治療用医薬組成物
|
EP3305321A4
(en)
*
|
2015-06-01 |
2019-01-23 |
University of Toyama |
THERAPEUTIC AND THERAPEUTIC PROCESS FOR PULMONARY HYPERTONIA
|
US20180201687A1
(en)
|
2015-07-07 |
2018-07-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to myosin 18a and uses thereof
|
WO2017060397A1
(en)
|
2015-10-09 |
2017-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from melanoma metastases
|
EP3370769A4
(en)
|
2015-11-03 |
2019-05-22 |
Janssen Biotech, Inc. |
SPECIFIC TO TIM-3 BINDING ANTIBODIES AND THEIR USE
|
AU2016349113A1
(en)
|
2015-11-04 |
2018-06-07 |
Astrazeneca Ab |
Dipeptidyl peptidase-4 and periostin as predictors of clinical response to eosinophil-targeted therapeutic agents in eosinophilic diseases
|
US11649262B2
(en)
|
2015-12-28 |
2023-05-16 |
Chugai Seiyaku Kabushiki Kaisha |
Method for promoting efficiency of purification of Fc region-containing polypeptide
|
EP3419999B1
(en)
|
2016-02-26 |
2021-08-04 |
(INSERM) Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity for btla and uses thereof
|
EP3431102A4
(en)
|
2016-03-14 |
2019-09-25 |
Chugai Seiyaku Kabushiki Kaisha |
THERAPEUTIC MEDICINE INDUCING CELLULAR INJURY FOR USE IN THE TREATMENT OF CANCER
|
US11242408B2
(en)
*
|
2016-06-14 |
2022-02-08 |
Advanced Biodesign |
Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis
|
TWI790206B
(zh)
|
2016-07-18 |
2023-01-21 |
法商賽諾菲公司 |
特異性結合至cd3和cd123的雙特異性抗體樣結合蛋白
|
KR102487356B1
(ko)
|
2016-07-29 |
2023-01-12 |
엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔 |
종양 관련 대식세포를 표적화하는 항체 및 이의 용도
|
TW202300515A
(zh)
|
2016-10-20 |
2023-01-01 |
法商賽諾菲公司 |
抗chikv抗體及其用途
|
US11773163B2
(en)
|
2016-11-21 |
2023-10-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the prophylactic treatment of metastases
|
JPWO2018139404A1
(ja)
*
|
2017-01-24 |
2019-11-14 |
協和キリン株式会社 |
放射線障害の治療又は予防剤並びに治療又は予防方法
|
JP2020510432A
(ja)
|
2017-03-02 |
2020-04-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Nectin−4への特異性を有する抗体及びその使用
|
KR102584011B1
(ko)
|
2017-03-16 |
2023-09-27 |
이나뜨 파르마 에스.에이. |
암 치료를 위한 조성물 및 방법
|
WO2019013308A1
(ja)
|
2017-07-13 |
2019-01-17 |
協和発酵キリン株式会社 |
抗bril抗体及び該抗体を用いたbril融合タンパク質の安定化方法
|
KR20200029469A
(ko)
|
2017-07-18 |
2020-03-18 |
쿄와 기린 가부시키가이샤 |
항인간 ccr1 모노클로날 항체
|
US11174322B2
(en)
|
2017-07-24 |
2021-11-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies and peptides to treat HCMV related diseases
|
MX2020003219A
(es)
|
2017-09-21 |
2020-07-20 |
Imcheck Therapeutics Sas |
Anticuerpos que tienen especificidad para btn2 y usos de los mismos.
|
RU2698048C2
(ru)
*
|
2017-10-03 |
2019-08-21 |
Закрытое Акционерное Общество "Биокад" |
МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
|
EP3708589A4
(en)
|
2017-11-08 |
2021-08-11 |
Kyowa Kirin Co., Ltd. |
BIS SPECIFIC ANTIBODY BINDING TO CD40 AND EPCAM
|
KR20200096531A
(ko)
|
2017-12-12 |
2020-08-12 |
쿄와 기린 가부시키가이샤 |
항bmp10 항체 및 해당 항체를 유효 성분으로 하는, 고혈압 및 고혈압성 질환에 대한 치료제
|
CN109942706A
(zh)
|
2017-12-21 |
2019-06-28 |
三生国健药业(上海)股份有限公司 |
结合人il-5的单克隆抗体、其制备方法和用途
|
EP3807316B1
(en)
|
2018-06-18 |
2024-05-01 |
Innate Pharma |
Compositions and methods for treating cancer
|
WO2020004492A1
(ja)
|
2018-06-26 |
2020-01-02 |
協和キリン株式会社 |
Cell Adhesion Molecule3に結合する抗体
|
TW202012445A
(zh)
|
2018-06-26 |
2020-04-01 |
日商協和麒麟股份有限公司 |
與硫酸軟骨蛋白多醣-5結合之抗體
|
JPWO2020067541A1
(ja)
|
2018-09-28 |
2021-08-30 |
協和キリン株式会社 |
抗体組成物
|
US20220025058A1
(en)
|
2018-11-06 |
2022-01-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of acute myeloid leukemia by eradicating leukemic stem cells
|
WO2020105621A1
(ja)
|
2018-11-20 |
2020-05-28 |
株式会社ペルセウスプロテオミクス |
細胞内への鉄の取り込み阻害剤
|
US20220064260A1
(en)
|
2018-12-14 |
2022-03-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8+cd45rclow tregs
|
SG11202106990PA
(en)
|
2018-12-28 |
2021-07-29 |
Kyowa Kirin Co Ltd |
BISPECIFIC ANTIBODY BINDING TO TfR
|
CN111100210B
(zh)
*
|
2019-01-30 |
2022-04-19 |
武汉九州钰民医药科技有限公司 |
一种Fc融合蛋白及其应用
|
WO2020169472A2
(en)
|
2019-02-18 |
2020-08-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of inducing phenotypic changes in macrophages
|
MX2021011334A
(es)
|
2019-03-20 |
2021-12-10 |
Imcheck Therapeutics Sas |
Anticuerpos que tienen especificidad para btn2 y usos de los mismos.
|
EP3947446A1
(en)
|
2019-03-25 |
2022-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of taupathy disorders by targeting new tau species
|
EP3970743A4
(en)
|
2019-05-15 |
2023-02-15 |
Kyowa Kirin Co., Ltd. |
BISPECIFIC ANTIBODIES BINDING TO CD40 AND FAP
|
US20220220216A1
(en)
|
2019-05-15 |
2022-07-14 |
Kyowa Kirin Co., Ltd. |
Bispecific antibody binding to cd40 and gpc3
|
TW202110479A
(zh)
|
2019-05-16 |
2021-03-16 |
瑞典商阿斯特捷利康公司 |
使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法
|
MX2021015033A
(es)
|
2019-06-06 |
2022-01-18 |
Immatics Biotechnologies Gmbh |
Clasificacion con contraseleccion utilizando peptidos de secuencias similares.
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
WO2021023624A1
(en)
|
2019-08-02 |
2021-02-11 |
Orega Biotech |
Novel il-17b antibodies
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
CN114364699B
(zh)
|
2019-09-04 |
2024-03-29 |
株式会社英仙蛋白质科学 |
红细胞增多症治疗药
|
EP4056232A4
(en)
|
2019-09-13 |
2023-09-13 |
Kyowa Kirin Co., Ltd. |
DCR3 VARIANT
|
WO2021058763A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance antibodies and uses thereof
|
TW202126688A
(zh)
|
2019-09-27 |
2021-07-16 |
瑞典商阿斯特捷利康公司 |
使用貝那利珠單抗治療遲發性氣喘之方法
|
WO2021058729A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof
|
EP4039814A4
(en)
|
2019-10-02 |
2023-10-11 |
Kyushu University, National University Corporation |
METHOD FOR PRODUCING HEPARIN-LIKE SUBSTANCES, RECOMBINANT CELLS AND METHOD FOR THE PRODUCTION THEREOF
|
AU2020387034A1
(en)
|
2019-11-20 |
2022-06-02 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody-containing preparation
|
EP4061944A1
(en)
|
2019-11-22 |
2022-09-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Inhibitors of adrenomedullin for the treatment of acute myeloid leukemia by eradicating leukemic stem cells
|
CN114786718A
(zh)
|
2019-11-27 |
2022-07-22 |
株式会社英仙蛋白质科学 |
癌性腹膜炎的治疗药
|
US20230040928A1
(en)
|
2019-12-09 |
2023-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to her4 and uses thereof
|
WO2021144020A1
(en)
|
2020-01-15 |
2021-07-22 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
TW202140561A
(zh)
|
2020-02-14 |
2021-11-01 |
日商協和麒麟股份有限公司 |
與cd3結合之雙特異性抗體
|
AU2021249888A1
(en)
|
2020-04-01 |
2022-10-27 |
Kyowa Kirin Co., Ltd. |
Antibody composition
|
WO2021228956A1
(en)
|
2020-05-12 |
2021-11-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to treat cutaneous t-cell lymphomas and tfh derived lymphomas
|
TW202214692A
(zh)
|
2020-06-05 |
2022-04-16 |
瑞典商阿斯特捷利康公司 |
治療患有鼻瘜肉的患者的重度氣喘之方法
|
CN111825763B
(zh)
*
|
2020-07-15 |
2022-04-19 |
扬州大学 |
流感病毒ha蛋白茎部特异性单克隆抗体及其制备方法和应用
|
CN114075282B
(zh)
*
|
2020-08-20 |
2024-01-02 |
南京融捷康生物科技有限公司 |
Il-5的结合分子及其制备方法和应用
|
CA3190586A1
(en)
|
2020-09-04 |
2022-03-10 |
Merck Patent Gmbh |
Anti-ceacam5 antibodies and conjugates and uses thereof
|
KR20220035655A
(ko)
|
2020-09-14 |
2022-03-22 |
아주대학교산학협력단 |
인터루킨-4 수용체 알파 서브유닛과 인터루킨-5 수용체 알파 서브유닛에 동시에 결합하는 이중특이항체 및 이의 용도
|
KR20220035656A
(ko)
*
|
2020-09-14 |
2022-03-22 |
아주대학교산학협력단 |
인간 IL-5Rα에 결합하는 항체 및 이의 용도
|
WO2022075439A1
(ja)
|
2020-10-08 |
2022-04-14 |
国立大学法人東海国立大学機構 |
抗トランスフェリンレセプター抗体の薬効又は感受性の判定方法
|
WO2022129301A1
(en)
|
2020-12-17 |
2022-06-23 |
Astrazeneca Ab |
Anti-il5r antibody formulations
|
WO2022184805A1
(en)
|
2021-03-03 |
2022-09-09 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein
|
IL308257A
(en)
|
2021-05-05 |
2024-01-01 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins that uniquely bind PRAME
|
KR20240038028A
(ko)
|
2021-07-27 |
2024-03-22 |
이매틱스 바이오테크놀로지스 게엠베하 |
Ct45에 특이적으로 결합하는 항원 결합 단백질
|
WO2023006919A1
(en)
|
2021-07-29 |
2023-02-02 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
HUMANIZED ANTI-HUMAN βIG-H3 PROTEIN AND USES THEREOF
|
WO2023027177A1
(ja)
|
2021-08-26 |
2023-03-02 |
協和キリン株式会社 |
Cd116およびcd131に結合するバイスペシフィック抗体
|
WO2023027164A1
(ja)
|
2021-08-26 |
2023-03-02 |
株式会社ペルセウスプロテオミクス |
Ros(活性酸素種)産生増強剤
|
WO2023170239A1
(en)
|
2022-03-09 |
2023-09-14 |
Merck Patent Gmbh |
Methods and tools for conjugation to antibodies
|
CN115043933B
(zh)
*
|
2022-03-31 |
2023-08-08 |
深圳市人民医院 |
靶向新冠病毒的纳米抗体及其制备方法和应用
|
WO2024056668A1
(en)
|
2022-09-12 |
2024-03-21 |
Institut National de la Santé et de la Recherche Médicale |
New anti-itgb8 antibodies and its uses thereof
|